Group 1 - The stock price of Jinghua Pharmaceutical (002349) closed at 7.7 yuan on January 16, 2026, with an increase of 0.92% and a turnover rate of 2.0% [1] - The trading volume was 163,000 hands, with a transaction amount of 125 million yuan [1] Group 2 - The company’s subsidiary, Dongli (Nantong) Chemical Co., Ltd., established a strategic partnership with Beijing Aerospace Test Technology Research Institute in 2023 [2] - The product, methyl hydrazine, has been recognized by China Aerospace Science and Technology Corporation (101 Institute) for compliance with aerospace product standards [2] - The company indicated that any significant sales contracts will be disclosed through temporary announcements, and the current business has a minor impact on the company's performance [2] Group 3 - On January 16, the net inflow of main funds was 12.17 million yuan, indicating active participation from major investors [2] - Retail investors showed a net outflow of 15.04 million yuan, while speculative funds had a net inflow of 2.87 million yuan [2]
股市必读:精华制药(002349)1月16日董秘有最新回复